Archive

Check out previous Synapse insights from our International Life Sciences team.

在此页面上

    9 观点

    9 观点

    • 在此页面上

    Orphan drug protection

    更多
    点击此处了解更多

    To use or not to use?

    更多
    点击此处了解更多

    Updated post-market surveillance (PMS) rules for medical devices in the UK: differences from the EU regulations

    更多
    点击此处了解更多

    Reporting clinical trial results to the market

    更多
    点击此处了解更多

    European Court of Justice on advertising for biocidal products: ‘Skin-friendly’ is misleading and violates EU law

    更多
    点击此处了解更多

    Regulatory update: microplastics and medical devices

    更多
    点击此处了解更多

    Labelling requirements for medical devices under the new EU Product Safety Regulation

    更多
    点击此处了解更多

    Medical device manufacturers: control your supply chain for MDR and IVDR requirements

    更多
    点击此处了解更多

    The EU torpedoes itself in cross-border patent disputes

    更多
    点击此处了解更多
    行业 酒店与休闲

    Return to

    Synapse home

    Go to Synapse main hub

    © Taylor Wessing